Ballhausen and colleagues collected tissue from CRC and endometrial MSI cancers and studied the immunogenicity of neo-antigens derived from coding microsatellites in B2M-wild-type tumors and B2M-mutant tumors [72]. This evidence concerns the gene B2M and cancer.